# Journal Review 001

Objective: determine whether the Research Journal improves understanding, not trading.

## Evidence Review At 10 Observations

Observations reviewed: OBS_0001 through OBS_0010.

Knowledge converted:
- KNW_0004: Architecture readiness can exceed evidence maturity even when the verified graph is auditable.
- KNW_0006: Closed outcomes are the binding constraint for many AEGIS research claims.
- KNW_0008: Technical Strategy Factory claims require relationship-specific support, not broad or baseline evidence.
- KNW_0009: Read-only research governance can preserve learning while preventing premature action.

Failures converted:
- FAIL_0004: Architecture maturity did not imply comparable evidence maturity.
- FAIL_0006: Observation accumulation did not quickly produce meaningful outcome evidence.
- FAIL_0008: Standalone technical-indicator claims did not survive fixture review.
- FAIL_0009: Active sleeves did not produce broadly distributed candidate flow.

Remaining contradiction:
- OBS_0005 is supported but too broad; it should remain a parent contradiction until split pressure is real.
- OBS_0009 narrows the same issue to verified graph readiness versus runtime readiness.

## Evidence Review At 15 Observations

Observations reviewed: OBS_0011 through OBS_0015.

Knowledge converted:
- KNW_0005: Paper workflow progress is not equivalent to live readiness.
- KNW_0011: Research triage is currently more informative than capital review.

Failures converted:
- FAIL_0005: Paper workflow progress did not indicate live readiness progress.
- FAIL_0010: Capital allocation review was not useful while evidence remained underpowered or blocked.
- FAIL_0012: Macro readiness gaps could not be resolved by expanding workflow behavior.

Remaining contradiction:
- Paper, research, and macro artifacts can advance as review surfaces while live or capital authority stays disabled.

## Evidence Review At 20 Observations

Observations reviewed: OBS_0016 through OBS_0020.

Knowledge converted:
- KNW_0007: Candidate generation needs certification and governance evidence before it becomes useful research evidence.
- KNW_0010: Deprecation should wait until runtime truth no longer requires the legacy artifact.
- KNW_0012: Warnings are useful journal inputs when they prevent clean-state overconfidence.
- KNW_0013: The journal improves understanding when it compresses evidence gaps into reusable claims.

Failures converted:
- FAIL_0007: Candidate volume was not a reliable proxy for candidate quality.
- FAIL_0011: Legacy compatibility layers could not be retired by architecture decision alone.
- FAIL_0013: A clean graph audit state did not mean research understanding was mature.

Remaining contradiction:
- OBS_0018 shows architecture migration intent conflicting with runtime truth dependency requirements.

## Numbering Note

KNW_0001 through KNW_0003 and FAIL_0001 through FAIL_0003 are not persisted files in this repository. They were conceptual seed examples from the V0 design discussion. Persisted knowledge and failure files begin at KNW_0004 and FAIL_0004 to preserve the sequence used during the OBS_0005 review. No placeholder files were created.

## Current Journal Status

Status: Feature frozen, human-readable, validation passing.

Current inventory:
- 20 observations
- 15 knowledge entries
- 13 failures
- Journal Review 001

First usefulness test: PASSED for understanding. The journal made repeated evidence gaps easier to name, compare, and reuse without adding architecture.

Trading improvement has not been tested. The journal should not be evaluated on trading outcomes in this phase.

Selected next action: Evidence-check OBS_0006.

Reason: OBS_0006 remains a central decision-usefulness question: research attention allocation may be more useful than capital allocation while evidence remains underpowered. It now follows naturally from the outcome-maturity and factory-evidence reviews.

Expected output of next action: determine whether attention allocation remains more useful than capital allocation, or whether any evidence now supports capital review.

## OBS_0001 Evidence Review

Question: is low sleeve candidate production caused by poor sleeve quality, lack of evidence maturity, candidate-generation bottlenecks, or normal market conditions?

Evidence found:
- Sleeve throughput diagnostics: 5 of 10 sleeves produced candidates; 4 sleeves were dormant and 1 was blocked.
- Sleeve throughput evidence scorecard: 5 sleeves were flowing, 4 were healthy with no candidate, and 1 needed data; no sleeves were marked as needing repair or governance.
- Non-producing sleeve causes included valid no-signal conditions, trigger thresholds not met, no signals generated, and insufficient market data.
- Candidate diagnostics: 8 sleeves ran, 42 raw signals were seen, 1 candidate was generated, 41 candidate-conversion rejections occurred, and 1 portfolio-scoring rejection occurred.
- Candidate diagnostics also showed non-certified candidate snapshots and portfolio gate suppression as bottlenecks.
- Research quality and outcome artifacts still showed underpowered evidence and 0 outcome-validation closed outcomes, limiting claims about durable sleeve quality.

Classification:
- A. Poor sleeve quality: UNSUPPORTED.
- B. Lack of evidence maturity: PARTIAL CONTRIBUTOR. It limits confidence in sleeve quality claims but does not by itself explain same-day candidate production.
- C. Candidate-generation bottlenecks: SUPPORTED. Certification, conversion, and portfolio-scoring gates reduced actionable candidates.
- D. Normal market conditions: SUPPORTED. Several sleeves ran and produced no qualifying setup under valid no-signal or threshold-not-met conditions.

Result: OBS_0001 is no longer unexplained. It is a supported mixed-cause observation, with primary causes C and D and a secondary evidence-maturity caveat. No refined observation was created because existing observations already cover candidate bottlenecks and evidence maturity.

New learning objects:
- KNW_0014: Low sleeve candidate production can reflect normal no-signal conditions and candidate-generation bottlenecks rather than poor sleeve quality.
- FAIL_0014: Low sleeve candidate production did not support poor sleeve quality as the primary cause.

Recommended next action: Evidence-check OBS_0016, focused on non-certified candidate snapshots and candidate-conversion rejections.

## OBS_0016 Evidence Review

Question: why did 42 raw signals produce only 1 generated candidate and 41 candidate-conversion rejections?

Evidence found:
- Candidate generation diagnostics: 8 sleeves ran, 42 raw signals were recorded, 1 candidate was generated, 41 candidates were rejected in the aggregate candidate-conversion count, and 1 rejection appeared at portfolio scoring.
- Candidate contracts: 1 candidate contract was created, contract validation status was PASS, no candidate contracts were rejected, and no top missing contract fields were reported.
- Detailed raw-signal rows: 40 signals were rejected at PORTFOLIO_GATE with PORTFOLIO_GATE_SUPPRESSED and classification EXPECTED.
- Detailed raw-signal rows: 2 signals were rejected at PORTFOLIO_SCORING with NON_CERTIFIED_CANDIDATE_SNAPSHOT and safety_related true.
- Portfolio activation gate: 40 suppressions had ONE_PRIMARY_PER_REGIME_BUCKET_SUPPRESSED plus PORTFOLIO_STATE_DEGRADED_NO_SUPPRESSION_APPLIED.
- Portfolio activation gate: 2 allowed provisional intents were NON_CERTIFIED, CERTIFICATION_PENDING, read-only, and not execution eligible.
- Portfolio scoring coverage: 40 candidates were SUPPRESSED because of PORTFOLIO_GATE_SUPPRESS; 2 were CANDIDATE_CREATED but NOT_EXECUTABLE because of NON_CERTIFIED_CANDIDATE_SNAPSHOT; 310 coverage rows were NO_SIGNAL with NO_INTENT_DECLARED.
- Verified graph and audit handoff: graph status was READY with no audit blockers, while runtime readiness remained BLOCKED and trade advice remained forbidden.

Classification result:
- Non-certified candidate snapshots: DATA_OR_CERTIFICATION_DEFECT. The two affected provisional intents were allowed by the portfolio gate but remained non-executable because final EOD certification was pending.
- Candidate conversion rejections: TOO_BROAD_SPLIT_REQUIRED. The aggregate rejection count mixes expected portfolio suppression with certification-related blocks, so it should not be interpreted as one failure mode.
- Portfolio gate suppression: EXPECTED_SUPPRESSION. The 40 suppressions were governed by one-primary-per-regime-bucket and degraded-portfolio-state reason codes.
- Normal no-signal conditions: EXPECTED_SUPPRESSION. Portfolio scoring coverage included 310 NO_SIGNAL rows with NO_INTENT_DECLARED, outside the 42 raw-signal conversion question.
- Data/certification defects: DATA_OR_CERTIFICATION_DEFECT for the two non-certified candidate snapshots; not supported as the cause of the 40 portfolio suppressions.
- Expected governance suppression: EXPECTED_SUPPRESSION for the 40 portfolio-gate suppressions.

Result: OBS_0016 is supported. Non-certified candidate snapshots were a real bottleneck for two otherwise allowed provisional intents, but the larger 42-to-1 funnel was mostly expected governance suppression, not a broad candidate-generation defect.

New learning objects:
- KNW_0015: Raw signals should be separated into expected portfolio suppression and certification bottlenecks before judging candidate-generation quality.

No failure entry was created because the core observation was supported rather than disproven.

Recommended next action: Evidence-check OBS_0019 to determine whether daily research integrity warnings recur or clear.

## OBS_0019 Evidence Review

Question: do daily research integrity warnings represent a recurring systemic issue, expected operational noise, a cleared condition, or a reusable caution?

Evidence found:
- Daily research integrity audit for 2026-06-01: WARN, 0 blockers, 5 warnings, 5 issues. Category summary was candidate_integrity: 1 and sleeve_health: 4.
- Daily research integrity audit for 2026-06-02: WARN, 0 blockers, 5 warnings, 5 issues. Category summary was candidate_integrity: 1 and sleeve_health: 4.
- Daily research integrity audit for 2026-06-03: WARN, 0 blockers, 5 warnings, 5 issues. Category summary was candidate_integrity: 1 and sleeve_health: 4.
- The recurrent candidate-integrity warning was stale candidate input artifacts, with recommended next step to refresh stale candidate inputs and rerun diagnostics.
- The recurrent sleeve-health warnings were REDESIGN or NEEDS_DATA recommendations that should be treated as repair investigation, not audit blockers.
- Daily research integrity audit for 2026-06-04: FAIL, 2 blockers, 5 warnings, 7 issues. The primary issue was to resolve verified runtime graph readiness before trusting daily research integrity.
- The 2026-06-03 audit safety section reported verified graph status READY and audit blocker count 0 at that audit time, while later strict graph validation for 2026-06-03 became blocked by missing trend_eq_realized_vs_unrealized_diagnostic evidence.
- All reviewed integrity audit artifacts preserved safety gates: read-only, no live trading, no real capital, no broker execution, no trade advice, and no mutation.

Classification:
- A. recurring systemic issue: SUPPORTED for repeated candidate-integrity and sleeve-health warning categories across 2026-06-01 through 2026-06-03.
- B. expected operational noise: PARTIAL. The sleeve-health warnings explicitly say REDESIGN/PAUSE should be treated as repair investigation, not audit blockers, but recurrence means they are not ignorable noise.
- C. cleared condition: UNSUPPORTED. The condition did not clear in the available sequence and escalated to FAIL on 2026-06-04.
- D. reusable caution: SUPPORTED. The warnings are useful as non-blocking evidence-quality cautions that prevent clean-state overconfidence.

Result: OBS_0019 is supported as a reusable caution and a recurring warning pattern. It is not a cleared condition. No architecture change is warranted.

New learning objects:
- KNW_0016: Daily research integrity warnings should be treated as reusable caution signals until recurrence or clearance is checked across days.
- FAIL_0015: Daily research integrity warnings were not merely one-day operational noise or a cleared condition.

Recommended next action: Evidence-check OBS_0002, focused on whether outcome maturity remains underpowered versus improving.

## OBS_0002 Evidence Review

Question: has outcome maturity remained underpowered, improved enough to change the observation, or become blocked by evidence contracts?

Evidence found:
- Paper position ledger: 57 positions and 57 open positions on 2026-06-01; 62 positions and 62 open positions on 2026-06-02; 63 positions, 51 open positions, and 12 closed positions on 2026-06-03; 63 positions, 58 open positions, and 5 closed positions on 2026-06-04.
- Validation samples: included closed/resolved samples increased from 2 on 2026-06-01 to 5 on 2026-06-02 to 12 on 2026-06-03, then fell to 5 on 2026-06-04. Total samples stayed high at 57 to 63, with excluded samples ranging from 51 to 58.
- Outcome registry: closed outcomes increased from 2 on 2026-06-01 to 5 on 2026-06-02 to 12 on 2026-06-03, then returned to 5 on 2026-06-04. Open outcomes remained high: 55, 57, 51, and 58.
- Outcome flow audit on 2026-06-03: 63 total positions opened, 52 currently open, 11 closed positions seen by evidence certification, 0 outcome-validation closed outcomes, flow health BLOCKED, and rule zero_closed_samples_are_not_working_evidence true.
- Sleeve performance truth on 2026-06-03: 63 paper trades, 51 open positions, 12 closed positions, data quality PASS, and all 12 closed positions came from C2_TREND_EQ_PRIMARY_V1. Other sleeves had open positions but 0 closed positions.
- Sleeve performance truth on 2026-06-04: 63 paper trades and 63 open positions, but data quality was BLOCKED_MISSING_AUTHORITY because paper_position_events authority was missing.
- Research quality engine from 2026-06-01 through 2026-06-04: 10 hypotheses, 6 underpowered, 4 blocked, and 0 ready for capital review on every reviewed day.
- Research allocation recommendation from 2026-06-01 through 2026-06-04: 0 ready for capital review on every reviewed day.

Key question answers:
- How many paper positions exist? 57 on 2026-06-01, 62 on 2026-06-02, 63 on 2026-06-03, and 63 on 2026-06-04.
- How many are open? 57, 62, 51, and 58 by paper position ledger across 2026-06-01 through 2026-06-04.
- How many are closed/resolved? Validation samples show 2, 5, 12, and 5 included closed/resolved outcomes across those days.
- How many closed/resolved outcomes are included in validation samples? 2 on 2026-06-01, 5 on 2026-06-02, 12 on 2026-06-03, and 5 on 2026-06-04.
- Are outcome samples concentrated? Yes. On 2026-06-03, sleeve performance truth showed all 12 closed paper positions came from C2_TREND_EQ_PRIMARY_V1.
- Are any sleeves ready for capital review? No. Research quality and allocation artifacts showed 0 ready for capital review across 2026-06-01 through 2026-06-04.
- Is evidence maturity improving or merely accumulating open observations? It improved through 2026-06-03, but remained underpowered and concentrated; 2026-06-04 introduced evidence-contract blockage rather than clear maturity progress.

Classification result: IMPROVING_BUT_UNDERPOWERED.

Rationale: OBS_0002 remains valid, but the most precise classification is improvement without maturity. Closed/resolved validation samples grew from 2 to 12 by 2026-06-03, yet open positions still dominated, closed outcomes were concentrated in one sleeve, no hypotheses or sleeves were ready for capital review, and 2026-06-04 sleeve performance truth was blocked by missing authority.

New learning objects:
- KNW_0017: Outcome maturity can improve while still remaining underpowered when closed outcomes are few and sleeve-concentrated.

No failure entry was created because the prior observation was refined, not disproven.

Recommended next action: Evidence-check OBS_0003, focused on whether Technical Strategy Factory evidence remains weak, has improved, or should be split by relationship/evidence type.

## OBS_0003 Evidence Review

Question: does Technical Strategy Factory evidence remain weak, improve enough to change the observation, or require a split by evidence or relationship type?

Evidence found:
- Alpha Factory POC review: 15 evidence items, 3 supporting items, 6 contradictory items, 9 zero-sample items, output reproducible, lineage complete, but discovery claim invalid and evidence insufficient.
- POC review findings: Real Yield Shock Response was supported only by GLD shock to SLV forward returns, while real-yield support sample count was 0; several zero-sample artifacts still carried effect directions.
- Evidence Test v2: 62 blocked evidence items, 0 supported evidence items, 7 false-positive-prone relationships, and 9 injection-insensitive relationships. Verdicts showed improved controls and specificity but said not to claim discovery advantage.
- Technical conditional pattern pilot: 90 pattern evidence items and 26 supported evidence items, with real-data technical patterns found; however valid RAC count was 0, baseline matched or exceeded the pipeline, technical conditional advantage was absent, and real-market discovery claims were prohibited.
- Technical conditional failure attribution: primary failure mode was CONDITION_TOO_CLOSE_TO_PATTERN, with pivot recommended and better technical pattern definitions required.
- Deterministic fixture retest v2: no qualifying support and no valid RAC fixture IDs; Evidence Test v2 improved over v1, but injected SPY:VIX still lacked qualifying support.
- Repaired-feature fixture retest: valid deterministic fixture candidates appeared and false-positive control was acceptable, but the minimum next action was hostile out-of-fixture rebenchmark and no broad Alpha Factory success claim.
- Non-naive evidence test and in-fixture rebenchmark: question productivity and non-naive support improved, with one qualified research asset candidate in the in-fixture rebenchmark.
- Out-of-fixture non-naive rebenchmark: qualified research asset candidate count was 0, unique supported evidence count was 0, discovery advantage was absent, and V2 did not generalize.
- Out-of-fixture benchmark: POC did not generalize, baseline matched or exceeded POC, and the candidate was overnamed.
- Generated hypothesis validation proof: generated hypotheses reached paper observation flow but did not reach validation samples or outcomes; primary bottleneck was data readiness / shadow validation.

Key question answers:
- Are standalone technical-indicator claims still weak? Yes. Broad and standalone claims remain evidence-insufficient, false-positive-prone, baseline-recoverable, or non-generalizing.
- Are any technical-strategy claims supported when paired with mechanisms, regimes, or context? Partially. Real-data technical patterns and controlled fixture candidates exist, but they do not yet support broad discovery or real-market claims.
- Are failures concentrated in indicator-only claims? The strongest failures are in standalone, broad, baseline-recoverable, and out-of-fixture claims. Context-linked or repaired-feature tests show improvement but remain unproven.
- Are blocked evidence items still dominant? Yes for Evidence Test v2: 62 blocked and 0 supported. Other artifacts show improved controlled evidence, but not broad support.
- Did recent validation plans improve evidence quality or only define future work? Both. Controls and specificity improved, but most artifacts still define required future work before any broad success or discovery claim.

Classification result: EVIDENCE_TYPE_SPLIT_REQUIRED.

Rationale: OBS_0003 is supported, but the reusable lesson is more precise than technical analysis is weak. Standalone indicator and broad discovery claims remain weak. Mechanism-, relationship-, or context-linked technical structures have some controlled or in-fixture evidence, but remain unproven out of fixture and should not be treated as durable claims.

New learning objects:
- KNW_0018: Technical Strategy Factory evidence must distinguish standalone indicator claims from mechanism- or context-linked technical structure.
- FAIL_0016: Standalone technical-indicator evidence did not support durable Technical Strategy Factory claims.

Recommended next action: Evidence-check OBS_0006, focused on whether research attention allocation remains more useful than capital allocation while evidence remains underpowered.

## OBS_0006 Evidence Review

Question: does research attention allocation remain more useful than capital allocation while evidence remains underpowered, or does current AEGIS evidence now support capital review?

Evidence found:
- Verified runtime graph for 2026-06-03: graph_status READY.
- Capital authority readiness domain for 2026-06-03: status NOT_REQUIRED, capital_allocation_allowed false, and broker_execution_allowed false.
- Research quality engine for 2026-06-03: 10 hypotheses, 6 underpowered, 4 blocked, 0 watch, and 0 ready for capital review.
- Hypothesis decision policy for 2026-06-03: 5 CONTINUE, 3 REDESIGN, 1 NEEDS_DATA, 1 DECREASE_ATTENTION, 0 INCREASE_ATTENTION, and 0 READY_FOR_CAPITAL_REVIEW. Each decision remained read-only with no real capital, no live trading, no broker execution, and no trade advice.
- Research allocation recommendation for 2026-06-03: 5 HOLD, 4 PAUSE, 1 DECREASE, 0 INCREASE, and 0 CAPITAL_REVIEW. Recommendations were allocation-review guidance only, with allocation mutation false and real_capital_allowed false.
- Research capital allocation for 2026-06-03: 7 research-program decisions, all allocation_type RESEARCH_ATTENTION_ONLY. It recommended 1 INCREASE, 1 INVESTIGATE_MORE, and 5 REDUCE, and each row explicitly stated it was not trade sizing or live capital allocation.
- Research capital allocation self-check for 2026-06-03: ok true, failure_count 0, allocation_instructions_allowed false, read_only true, trade_advice_allowed false, broker_execution_allowed false, and live_trading_allowed false.
- Validation samples for 2026-06-03: 63 total samples, 12 closed or resolved outcomes, 12 included samples, and 51 excluded samples.
- Outcome registry for 2026-06-03: 63 paper positions, 12 closed outcomes, 51 open outcomes, and 12 resolved outcomes.
- Hypothesis outcome ledger for 2026-06-03: 9 hypotheses, 12 usable validation samples, 51 open positions, and all 12 usable validation samples came from HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1; the other 8 hypotheses had 0 usable validation samples and were UNDERPOWERED.
- Statistical sufficiency for 2026-06-03: 9 hypotheses, 8 underpowered, 1 validation_ready, and 0 validated.
- Sleeve performance truth for 2026-06-03: 63 paper trades, 51 open positions, 12 closed positions, data quality PASS, and all 12 closed paper positions came from C2_TREND_EQ_PRIMARY_V1.
- Sleeve evidence certification for 2026-06-03: 5 evaluated sleeves, 5 UNDERPOWERED, 0 positive evidence, and sample statuses of 1 BUILDING_SAMPLE and 4 ZERO_SAMPLE.
- Outcome flow audit for 2026-06-03: 63 total positions opened, 52 currently open positions, 11 closed positions seen by evidence certification, 0 outcome-validation closed outcomes, flow health BLOCKED, and zero_closed_samples_are_not_working_evidence true.
- Sleeve throughput evidence scorecard for 2026-06-03: 5 sleeves FLOWING, 4 HEALTHY_NO_CANDIDATE, 1 NEEDS_DATA, 0 NEEDS_REPAIR, and 0 NEEDS_GOVERNANCE.

Key question answers:
- Are any hypotheses or sleeves ready for capital review? No. Research quality, hypothesis decision policy, and research allocation recommendation all showed 0 ready for capital review; sleeve evidence certification showed 0 positive evidence and all evaluated sleeves UNDERPOWERED.
- Are paper outcomes sufficiently mature to support capital allocation decisions? No. The 12 usable validation samples were concentrated in one hypothesis and one sleeve, 51 positions remained open, statistical sufficiency had 0 validated hypotheses, and outcome flow audit still reported blocked flow with 0 outcome-validation closed outcomes.
- Does evidence remain underpowered? Yes. The strongest evidence is improved sample accumulation in trend persistence, but AEGIS still classified 6 of 10 research-quality hypotheses as underpowered, 4 as blocked, 8 of 9 statistical-sufficiency hypotheses as underpowered, and all 5 sleeve evidence certification rows as UNDERPOWERED.
- Does research attention allocation have clearer decision value than capital allocation right now? Yes. Attention artifacts produced differentiated read-only decisions: increase attention for PROGRAM_TREND_PERSISTENCE_V1, investigate more for PROGRAM_EVENT_DISLOCATION_V1, reduce attention for five weaker or stalled programs, hold five hypotheses, pause four, and decrease one. Capital review produced no eligible rows and remained disallowed.
- Are there sleeves or factories where research attention should increase, decrease, or remain unchanged based on evidence quality? Yes, at the research-program layer: increase PROGRAM_TREND_PERSISTENCE_V1, investigate more PROGRAM_EVENT_DISLOCATION_V1, reduce PROGRAM_DEFENSIVE_CONVEXITY_V1, PROGRAM_EQUITY_MEAN_REVERSION_V1, PROGRAM_RELATIVE_VALUE_SPREAD_V1, PROGRAM_SIMULATION_CONTROL_V1, and PROGRAM_VOLATILITY_RISK_PREMIUM_V1. At the hypothesis/sleeve layer, continue underpowered-but-flowing hypotheses, redesign stalled/no-paper-path hypotheses, handle macro calendar as needs data, and monitor flowing or healthy-no-candidate sleeves without treating them as capital-ready.
- Is capital allocation premature, or merely not yet evaluated? Premature for current evidence use. It is not an unexamined gap: capital review was evaluated by research quality, decision policy, allocation recommendation, capital authority readiness, and allocation self-check artifacts, and each kept capital review or allocation disabled.

Classification result: SUPPORTED.

Rationale: OBS_0006 is supported because the evidence surface can rank research attention but cannot support capital allocation. AEGIS has enough evidence to choose where to spend research effort next, especially sample accumulation, investigation, redesign, and data-source resolution. It does not have enough mature, distributed, closed, statistically sufficient paper outcomes to review or allocate real capital.

New learning objects:
- None. KNW_0011 already captures the reusable lesson that research triage is currently more informative than capital review, and this review strengthens that existing knowledge rather than creating a distinct one.

No failure entry was created because no prior expectation was newly disproven beyond the existing FAIL_0010.

Recommended next action: Evidence-check OBS_0007, focused on whether candidate generation volume still fails as a proxy for candidate quality after the OBS_0016 split.

## OBS_0007 Evidence Review

Question: does candidate generation volume still fail as a proxy for candidate quality after separating expected portfolio suppressions from certification bottlenecks in OBS_0016?

Evidence found:
- Verified runtime graph for 2026-06-03: graph_status READY.
- Candidate generation diagnostics for 2026-06-03: 8 sleeves run, 42 raw signals, 1 generated candidate, 41 rejected candidates, 1 valid candidate contract, and 0 rejected candidate contracts.
- Candidate generation rejection detail for 2026-06-03: 40 raw-signal rejections were PORTFOLIO_GATE / PORTFOLIO_GATE_SUPPRESSED / EXPECTED, and 2 raw-signal rejections were PORTFOLIO_SCORING / NON_CERTIFIED_CANDIDATE_SNAPSHOT / SAFETY_RELATED. The aggregate rejection-stage summary used a candidate-conversion lens, so the review used detailed rejection rows to separate expected governance suppression from certification bottlenecks.
- Candidate contracts for 2026-06-03: 1 governed candidate contract, for C2_CROSS_ASSET_TREND_V1. Candidate diagnostics classified it as VALID, entry-reference-price VALID and CERTIFIED, REVIEW_ONLY, with automatic approval, autonomous execution, and broker execution all false.
- Portfolio scoring for 2026-06-03: status DEGRADED, intents_scored_count 0, final_eod_certification_status PENDING, certification_state CERTIFICATION_PENDING, 40 PORTFOLIO_GATE_SUPPRESS reasons, 2 NON_CERTIFIED_CANDIDATE_SNAPSHOT reasons, and 0 executable scored intents.
- Sleeve throughput evidence scorecard for 2026-06-03: 5 sleeves FLOWING, 4 HEALTHY_NO_CANDIDATE, 1 NEEDS_DATA, 0 NEEDS_REPAIR, and 0 NEEDS_GOVERNANCE. Same-day raw-signal counts did not map cleanly to candidate or outcome inventory: C2_TREND_EQ_PRIMARY_V1 showed 53 candidates and 53 outcomes in the scorecard while same-day raw-signal count was 0, and C2_CROSS_ASSET_TREND_V1 showed 1 same-day raw signal with 5 candidate/outcome rows.
- Sleeve performance truth for 2026-06-03: 63 paper trades, 51 open positions, 12 closed positions, and all closed outcomes came from C2_TREND_EQ_PRIMARY_V1. Several sleeves had paper trades but 0 closed outcomes, so candidate or paper-trade count was not the same as outcome maturity.
- Hypothesis outcome ledger for 2026-06-03: 9 hypotheses, 63 paper positions, 51 open positions, 12 usable validation samples, and only HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 was VALIDATION_READY. HYP_EVENT_DISLOCATION_REPRICING_V1 had 23 candidates but 0 paper positions, 0 usable validation samples, and UNDERPOWERED status.
- Sleeve evidence certification for 2026-06-03: 5 evaluated sleeves, all 5 UNDERPOWERED, 0 positive evidence, 1 BUILDING_SAMPLE, and 4 ZERO_SAMPLE.
- Candidate-to-paper lifecycle for 2026-06-03: 1 valid candidate contract, 1 review-eligible candidate, 1 awaiting review, 1 constructed paper trade, 1 paper position created, and 0 promotion-eligible rows.

Key question answers:
- Do raw signal counts correlate with generated candidates? Weakly and inconsistently. The same-day diagnostics showed 42 raw signals but only 1 valid generated candidate, while the throughput scorecard showed candidate/outcome inventory that did not line up with same-day raw-signal counts.
- Do generated candidates correlate with accepted candidate contracts? Only after certification and governance filtering. On 2026-06-03, 42 raw signals produced 1 governed, valid, review-only candidate contract; 40 rejected rows were expected portfolio suppressions and 2 were safety-related certification bottlenecks.
- Do candidate counts correlate with evidence maturity? No. Sleeve evidence certification classified all 5 evaluated sleeves as UNDERPOWERED despite candidate and paper-trade inventories.
- Do candidate counts correlate with outcome maturity? No. The ledger showed 23 event-dislocation candidates with 0 paper positions and 0 usable validation samples, while trend had the only validation-ready hypothesis and all 12 usable validation samples. Candidate count identified activity, not mature outcomes.
- Are most rejected signals expected governance suppressions or true quality failures? Most were expected governance suppressions. The evidence does not support treating the 40 portfolio-gate suppressions as true quality failures. The 2 non-certified snapshot rows are safety-related certification failures or bottlenecks, not raw volume evidence.
- What metric appears more useful than raw candidate volume? Conversion quality is more useful: raw signal to portfolio-gate reason, certification status, valid governed candidate contract, portfolio-scoring status, paper observation, closed outcome, usable validation sample, and sleeve/hypothesis evidence maturity.

Classification result: SUPPORTED.

Rationale: OBS_0007 is supported, with the OBS_0016 split making the claim more precise. Candidate volume alone remains a poor proxy for candidate quality because raw counts mix expected portfolio governance suppression, certification readiness, review-only contract creation, paper observation flow, and immature outcome evidence. The useful measurement surface is not raw signal or candidate count; it is conversion quality through governance, certification, portfolio-scoring, paper-tracking, and closed-outcome maturity.

New learning objects:
- None. KNW_0007 and KNW_0015 already capture the reusable lesson that candidate generation requires certification/governance evidence and that raw signals must be split into expected portfolio suppression versus certification bottlenecks.

No failure entry was created because FAIL_0007 already captures the disproven expectation that candidate volume is a reliable proxy for candidate quality.

Recommended next action: Evidence-check OBS_0017, focused on whether portfolio-gate suppression is expected governance, a quality bottleneck, or a mixed class that should remain separated in journal interpretation.

## OBS_0017 Evidence Review

Question: are portfolio-gate suppressions expected governance behavior, candidate-quality bottlenecks, evidence-maturity bottlenecks, or a mixed class requiring separation?

Evidence found:
- Verified runtime graph for 2026-06-03: graph_status READY.
- Candidate generation diagnostics for 2026-06-03: 42 raw signals, 1 generated candidate, 41 rejected candidates, 1 valid candidate contract, and 0 rejected candidate contracts.
- Detailed candidate diagnostics: 40 raw signals were rejected at PORTFOLIO_GATE with rejection_reason PORTFOLIO_GATE_SUPPRESSED, expected_rejection true, rejection_classification EXPECTED, safety_related false, and portfolio_gate_decision SUPPRESS.
- Portfolio-gate reason codes on suppressed rows: ONE_PRIMARY_PER_REGIME_BUCKET_SUPPRESSED appeared on the 40 expected suppressions, while PORTFOLIO_STATE_DEGRADED_NO_SUPPRESSION_APPLIED appeared across the 42 detailed rejection rows. This supports interpreting the 40 gate suppressions as policy-shaped exposure selection, not failed candidate quality.
- Detailed candidate diagnostics also showed 2 non-portfolio-gate rows rejected at PORTFOLIO_SCORING with rejection_reason NON_CERTIFIED_CANDIDATE_SNAPSHOT, rejection_classification SAFETY_RELATED, and safety_related true. These are genuine bottlenecks, but they are certification bottlenecks rather than portfolio-gate suppressions.
- Portfolio scoring for 2026-06-03: status DEGRADED, intents_scored_count 0, final_eod_certification_status PENDING, and certification_state CERTIFICATION_PENDING. Coverage showed 40 PORTFOLIO_GATE_SUPPRESS reasons, 2 NON_CERTIFIED_CANDIDATE_SNAPSHOT reasons, 311 NO_INTENT_DECLARED reasons, and 42 NOT_EXECUTABLE rows.
- Portfolio scoring coverage classified 41 rows as SUPPRESSED, while detailed candidate diagnostics classified 40 raw-signal rows as PORTFOLIO_GATE_SUPPRESSED. The review treats this as a diagnostic-lens difference and relies on detailed raw-signal rows for the suppression count.
- Candidate contracts for 2026-06-03: 1 governed, valid, certified, review-only contract for C2_CROSS_ASSET_TREND_V1, with automatic approval, autonomous execution, and broker execution all false.
- Sleeve throughput evidence scorecard for 2026-06-03: 5 sleeves FLOWING, 4 HEALTHY_NO_CANDIDATE, 1 NEEDS_DATA, 0 NEEDS_REPAIR, and 0 NEEDS_GOVERNANCE. C2_TREND_EQ_PRIMARY_V1 remained FLOWING with 53 candidates, 53 outcomes, and 53 validation samples in the scorecard despite the same-day portfolio-gate suppressions.
- Sleeve performance truth for 2026-06-03: 63 paper trades, 51 open paper positions, 12 closed paper positions, and all 12 closed positions came from C2_TREND_EQ_PRIMARY_V1.
- Hypothesis outcome ledger for 2026-06-03: 9 hypotheses, 12 usable validation samples, 51 open positions, and only HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 was VALIDATION_READY. The other 8 hypotheses were UNDERPOWERED.
- Sleeve evidence certification for 2026-06-03: 5 evaluated sleeves, all 5 UNDERPOWERED, 0 positive evidence, 1 BUILDING_SAMPLE, and 4 ZERO_SAMPLE.

Determinations:
- How many suppressions were expected? 40 detailed raw-signal portfolio-gate suppressions were expected governance behavior.
- How many suppressions represent genuine bottlenecks? 0 of the detailed portfolio-gate suppressions were classified as safety-related or quality failures. The genuine bottlenecks in the same funnel were the 2 NON_CERTIFIED_CANDIDATE_SNAPSHOT rows, but those were certification bottlenecks at portfolio scoring, not portfolio-gate suppressions.
- Do suppressions improve research quality? Yes, cautiously. The suppressions improve research interpretation by preventing duplicate or lower-priority same-regime raw signals from being counted as actionable candidate-quality evidence. They do not prove candidate quality; they keep the candidate set cleaner for review.
- Are suppressions preventing outcome accumulation? Partially, but not as the primary bottleneck. They reduce same-day paper-observation breadth by stopping 40 raw signals before contract creation. However, C2_TREND_EQ_PRIMARY_V1 still had 53 paper trades and 12 closed outcomes, and the broader blocker was immature outcome evidence: all 5 evaluated sleeves remained UNDERPOWERED.
- Should suppression metrics be split? Yes. Suppression metrics should be separated into expected governance suppression, certification or data defects, candidate-quality failures, and outcome-maturity bottlenecks. Combining them would overstate quality failure and understate the role of governance policy.

Classification result: MIXED_CLASS.

Rationale: Portfolio-gate suppressions themselves were expected governance behavior on 2026-06-03, not candidate-quality failures. The broader suppression/conversion surface is mixed because adjacent rows in the same funnel exposed certification bottlenecks, and outcome artifacts exposed evidence-maturity bottlenecks. OBS_0017 should therefore be interpreted as a mixed class requiring separation: expected governance suppression should not be merged with certification defects or underpowered outcome evidence.

New learning objects:
- None. KNW_0015 already captures the reusable lesson that raw signals should be separated into expected portfolio suppression and certification bottlenecks before judging candidate-generation quality.

No failure entry was created because FAIL_0007 and FAIL_0014 already cover the disproven assumptions that candidate volume or low candidate production can be treated as direct quality evidence.

Recommended next action: Evidence-check OBS_0012, focused on whether research quality review still finds no hypotheses ready for capital review after the candidate-funnel evidence has been split.

## OBS_0012 Evidence Review

Question: does research quality review still correctly conclude that no hypotheses are ready for capital review after the candidate-funnel, certification, suppression, and outcome-maturity evidence has been refined?

Evidence found:
- Verified runtime graph for 2026-06-03: graph_status READY.
- Research quality engine for 2026-06-03: 10 hypotheses, 6 underpowered, 4 blocked, 0 watch, and 0 ready for capital review.
- Hypothesis decision policy for 2026-06-03: 5 CONTINUE, 3 REDESIGN, 1 NEEDS_DATA, 1 DECREASE_ATTENTION, 0 INCREASE_ATTENTION, and 0 READY_FOR_CAPITAL_REVIEW. Each decision remained read-only, with real_capital_allowed false and trade_advice_allowed false.
- Research allocation recommendation for 2026-06-03: 5 HOLD, 4 PAUSE, 1 DECREASE, 0 INCREASE, and 0 CAPITAL_REVIEW.
- Research capital allocation for 2026-06-03: 7 research-program decisions, all allocation_type RESEARCH_ATTENTION_ONLY. It recommended 1 INCREASE, 1 INVESTIGATE_MORE, and 5 REDUCE, with allocation_instructions_allowed false.
- Research capital allocation self-check for 2026-06-03: ok true, failure_count 0, read_only true, allocation_instructions_allowed false, trade_advice_allowed false, broker_execution_allowed false, and live_trading_allowed false.
- Validation samples for 2026-06-03: 63 total samples, 12 closed or resolved outcomes, 12 included samples, and 51 excluded samples.
- Hypothesis outcome ledger for 2026-06-03: 9 hypotheses, 63 paper positions, 51 open positions, 12 usable validation samples, and all 12 usable validation samples came from HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1. The other 8 hypotheses had 0 usable validation samples and were UNDERPOWERED.
- Statistical sufficiency for 2026-06-03: 9 hypotheses, 8 UNDERPOWERED, 1 VALIDATION_READY, and 0 VALIDATED.
- HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 was the only validation-ready hypothesis, but it still had only 12 usable samples against a 30-sample minimum, 18 additional samples needed, negative expectancy of -0.03493633, drawdown limit breach, excess return negative, low regime coverage, weak sample independence, insufficient confidence, and underpowered robustness.
- Sleeve evidence certification for 2026-06-03: 5 evaluated sleeves, all 5 UNDERPOWERED, 0 positive evidence, sample statuses of 1 BUILDING_SAMPLE and 4 ZERO_SAMPLE, and no certified sleeve-level positive evidence.
- Candidate-funnel refinement from OBS_0007 and OBS_0017 separated expected governance suppression from certification bottlenecks, but it did not create mature outcome evidence, positive sleeve evidence, or any capital-review eligibility.

Key question answers:
- Are any hypotheses now capital-review relevant? No. Research quality, hypothesis decision policy, and research allocation recommendation all showed 0 capital-review-ready rows.
- If not, why not? The refined funnel evidence explains candidate conversion better, but the outcome layer remains immature: 51 of 63 samples were excluded open positions, only 12 usable samples existed, those samples were concentrated in one hypothesis and one sleeve, and no hypothesis was validated.
- Which missing evidence is preventing capital review? Sufficient closed and included validation samples, distributed regime coverage, stronger sample independence, robustness evidence, positive sleeve evidence certification, acceptable outcome performance, and resolved data or paper-path evidence for blocked hypotheses.
- What is the blocker? The primary blocker is outcome maturity. Secondary blockers are evidence quality and concentration risk. Certification and paper-path or data-source gaps block a subset of hypotheses, but expected portfolio-gate suppression is not itself a capital-readiness blocker.
- What specific condition would cause the answer to change? At least one hypothesis would need enough closed, included, and sufficiently independent validation samples to meet the sufficiency threshold, exit UNDERPOWERED status, show acceptable performance without negative expectancy or drawdown/benchmark breaches, produce positive sleeve-level evidence, and be emitted as READY_FOR_CAPITAL_REVIEW or CAPITAL_REVIEW by the existing read-only research quality, decision-policy, and allocation-recommendation artifacts.

Classification result: STILL_NOT_READY.

Rationale: OBS_0012 remains supported in its current form. The refined candidate-funnel, certification, suppression, and outcome-maturity evidence makes the no-capital-review conclusion more specific rather than weaker. AEGIS has enough evidence to distinguish research attention decisions, but no hypothesis has mature, distributed, positive, closed-outcome evidence suitable for capital review.

New learning objects:
- None. KNW_0011 already captures the reusable lesson that research triage is currently more informative than capital review, and FAIL_0010 already captures the disproven expectation that capital allocation review is useful while hypotheses remain underpowered or blocked.

No failure entry was created because no prior expectation was newly disproven.

Recommended next action: Evidence-check OBS_0013, focused on whether hypothesis decision policy still appropriately favors continue, redesign, and data-needed states over capital-review readiness.

## OBS_0013 Evidence Review

Question: does the hypothesis decision policy appropriately favor CONTINUE, REDESIGN, and NEEDS_DATA instead of READY_FOR_CAPITAL_REVIEW given current evidence maturity?

Evidence found:
- Verified runtime graph for 2026-06-03: graph_status READY.
- Hypothesis decision policy for 2026-06-03: 10 decisions, with 5 CONTINUE, 3 REDESIGN, 1 NEEDS_DATA, 1 DECREASE_ATTENTION, 0 INCREASE_ATTENTION, 0 RETIRE_RECOMMENDED, and 0 READY_FOR_CAPITAL_REVIEW. Every row was read_only, real_capital_allowed false, and trade_advice_allowed false.
- Research quality engine for 2026-06-03: 10 hypotheses, 6 UNDERPOWERED, 4 BLOCKED, 0 watch, and 0 ready for capital review.
- Statistical sufficiency for 2026-06-03: 9 hypotheses, 8 UNDERPOWERED, 1 VALIDATION_READY, and 0 VALIDATED.
- Research allocation recommendation for 2026-06-03: 5 HOLD, 4 PAUSE, 1 DECREASE, 0 INCREASE, 0 RETIRE_REVIEW, and 0 CAPITAL_REVIEW. Each recommendation remained read-only, with real_capital_allowed false and trade_advice_allowed false.
- CONTINUE decisions were attached to underpowered hypotheses with evidence flow or a paper path, but with low validation sample count, included samples below minimum, insufficient closed samples, low regime coverage, weak sample independence, and underpowered robustness.
- REDESIGN decisions were attached to blocked hypotheses with stalled candidate generation, no candidate flow, no observation flow, no paper path, no included validation samples, and implementation incomplete or no-paper-path reason codes.
- The NEEDS_DATA decision was attached to the macro calendar fixture, with macro calendar data readiness needing a source, no data source, missing macro event calendar, no included validation samples, no paper path, and data-quality-blocked reason codes.
- HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 was the only validation-ready statistical-sufficiency row, but it still had only 12 usable samples against a 30-sample minimum, 18 additional samples needed, negative expectancy of -0.03493633, drawdown limit breach, excess return negative, low regime coverage, weak sample independence, insufficient confidence, and underpowered robustness. The policy therefore chose DECREASE_ATTENTION rather than capital review.
- Journal review context from OBS_0012 and journal_review_002 showed the same conclusion: refined candidate-funnel evidence improves triage, but does not create mature, distributed, positive outcome evidence or capital-review eligibility.

Key question answers:
- Are current policy outputs consistent with observed evidence maturity? Yes. The policy preserves research flow where evidence is accumulating, redesigns blocked or no-paper-path hypotheses, routes missing macro-calendar input to data resolution, and emits no capital-review rows when quality and sufficiency artifacts are underpowered or blocked.
- Would any hypothesis be incorrectly promoted if standards were relaxed? Yes. The most likely false promotion would be HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 because it is the only validation-ready statistical-sufficiency row, but relaxing standards would ignore insufficient sample count, negative expectancy, drawdown breach, negative excess return, weak independence, low regime coverage, and underpowered robustness. Event-dislocation could also be over-promoted if high candidate yield were mistaken for mature outcome evidence.
- Are CONTINUE, REDESIGN, and NEEDS_DATA decisions evidence-supported? Yes. CONTINUE is supported for underpowered but producing or paper-path-present hypotheses; REDESIGN is supported for blocked, stalled, no-flow, or no-paper-path hypotheses; NEEDS_DATA is supported for the macro-calendar fixture because the required source is missing.
- Is the policy appropriately conservative? Yes. It blocks capital review while allowing differentiated research learning to continue.
- Does the policy appear to be helping or hindering learning? Helping. It avoids false capital readiness while still separating accumulate-sample, redesign, decrease-attention, and data-source actions. That preserves useful learning paths without turning underpowered evidence into allocation claims.

Classification result: APPROPRIATELY_CONSERVATIVE.

Rationale: OBS_0013 is supported because the decision policy is conservative in the right direction. The observed evidence maturity does not justify READY_FOR_CAPITAL_REVIEW for any hypothesis, but it does justify continued sample accumulation for flowing underpowered hypotheses, redesign for blocked/no-paper-path hypotheses, and data-source resolution for macro-calendar evidence.

New learning objects:
- None. KNW_0011 already captures the reusable lesson that research triage is currently more informative than capital review, and the OBS_0012 review already captured the specific no-capital-review condition.

No failure entry was created because no prior expectation was newly disproven.

Recommended next action: Evidence-check OBS_0014, focused on whether low or absent candidate production should be interpreted as sleeve weakness, expected no-signal behavior, or missing evidence depending on governance and throughput diagnostics.

## OBS_0014 Evidence Review

Question: should low or absent candidate production be interpreted as sleeve weakness, expected no-signal behavior, governance suppression, missing evidence/data, or candidate-conversion bottleneck?

Evidence found:
- Verified runtime graph for 2026-06-03: graph_status READY.
- Sleeve throughput diagnostics for 2026-06-03: 10 total sleeves, 5 FLOWING, 4 DORMANT, 1 BLOCKED, and 0 UNDERPRODUCING.
- Sleeve throughput evidence classification scorecard for 2026-06-03: 5 FLOWING, 4 HEALTHY_NO_CANDIDATE, 1 NEEDS_DATA, 0 NEEDS_REPAIR, and 0 NEEDS_GOVERNANCE.
- Scorecard classification rules distinguished FLOWING, HEALTHY_NO_CANDIDATE, NEEDS_DATA, NEEDS_GOVERNANCE, NEEDS_REPAIR, and BLOCKED. HEALTHY_NO_CANDIDATE meant the system ran correctly but no valid governed candidate existed.
- Dormant sleeve signal-generation diagnostics for 2026-06-03: 4 dormant sleeves, with 2 VALID_NO_SIGNAL_CONDITIONS, 1 TRIGGER_THRESHOLDS_NOT_MET, 1 PRODUCER_RUNTIME_ERROR, 0 missing market data, 0 missing event data, 0 producer-not-invoked, 0 producer-not-registered, and 0 unknown blocker.
- C2_DEFENSIVE_TAIL_V1 was dormant with producer_invoked true, producer_registered true, market_data_status AVAILABLE, signal_producer_status NO_INTENT, raw_signal_count 0, dormant_reason_code VALID_NO_SIGNAL_CONDITIONS, and zero_signal_interpretation HEALTHY_SELECTIVITY.
- C2_MARKET_NEUTRAL_SPREAD_V1 was dormant with producer_invoked true, producer_registered true, market_data_status AVAILABLE, trigger_thresholds_met false, dormant_reason_code TRIGGER_THRESHOLDS_NOT_MET, and observed z values below the z_enter 2.0 threshold.
- C2_EVENT_DISLOCATION_V1 showed a PRODUCER_RUNTIME_ERROR / DUPLICATE_DAY_IN_MARKET_DATA path in dormant-sleeve diagnostics, while event-dislocation suppression and governance-trace diagnostics showed raw_signal_count 0, candidate_count 0, no rejected candidate attempts, and UNKNOWN_DETERMINISTIC_BLOCKER. This supports a data/runtime blocker diagnosis, not sleeve-quality weakness.
- C2_INTENT_SIMULATOR_V1 showed FILTERED_OUT / ACTIVE_SIMULATOR_NOT_PRESTART_REQUIRED / OPTIONAL_SIMULATION plus SLEEVE_INPUT_REQUIREMENT_BLOCKED. It was not evidence of a weak trading sleeve; it was an optional simulator/control path filtered by requirements.
- Candidate generation diagnostics for 2026-06-03: 8 sleeves ran, 42 raw signals, 1 generated candidate, 41 aggregate candidate-conversion rejections, 1 portfolio-scoring rejection, 1 valid candidate contract, 0 rejected candidate contracts, top_missing_candidate_fields empty, and operator_interpretation NORMAL_NO_SIGNAL.
- Raw signals by sleeve were concentrated in C2_TREND_EQ_PRIMARY_V1 with 40 raw signals, C2_CROSS_ASSET_TREND_V1 with 1, and C2_VOL_INCOME_DEFINED_RISK_V1 with 1. This shows that low candidate production was not the same as absent raw signal production.
- Detailed candidate diagnostics from OBS_0016 and OBS_0017 showed 40 PORTFOLIO_GATE / PORTFOLIO_GATE_SUPPRESSED / EXPECTED rows and 2 PORTFOLIO_SCORING / NON_CERTIFIED_CANDIDATE_SNAPSHOT / SAFETY_RELATED rows.
- Candidate contracts for 2026-06-03 showed 1 governed, valid, certified, review-only candidate contract, 0 rejected contracts, contract_validation_status PASS, and no missing contract fields.
- Portfolio scoring for 2026-06-03 remained DEGRADED with final EOD certification pending and 0 executable scored intents, separating certification/actionability from raw signal existence.
- Sleeve evidence certification for 2026-06-03: 5 evaluated sleeves, all 5 UNDERPOWERED, 0 positive evidence, 1 BUILDING_SAMPLE, and 4 ZERO_SAMPLE. This limited claims about durable sleeve quality even for sleeves with candidate or paper-observation inventory.
- Outcome maturity artifacts for 2026-06-03 showed 63 paper positions, 51 open positions, 12 usable validation samples, and all usable samples concentrated in HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 / C2_TREND_EQ_PRIMARY_V1. Candidate production and closed-outcome maturity were therefore separate surfaces.

Key question answers:
- When a sleeve produces no candidates, what distinguishes expected no-signal behavior from sleeve weakness? Expected no-signal behavior is supported when producer_invoked and producer_registered are true, market_data_status is AVAILABLE, trigger_evaluation_status is EVALUATED or EVALUATED_NO_SIGNAL, reason codes show NO_INTENT_DECLARED or threshold-not-met behavior, and the scorecard classifies the sleeve as HEALTHY_NO_CANDIDATE rather than NEEDS_REPAIR, NEEDS_DATA, NEEDS_GOVERNANCE, or BLOCKED.
- When raw signals exist but candidates do not, what distinguishes expected governance suppression from a bottleneck? Expected governance suppression is supported by detailed rejection rows with rejection_stage PORTFOLIO_GATE, rejection_reason PORTFOLIO_GATE_SUPPRESSED, expected_rejection true, rejection_classification EXPECTED, safety_related false, and explicit portfolio_gate_reason_codes. A conversion or certification bottleneck is supported by PORTFOLIO_SCORING / NON_CERTIFIED_CANDIDATE_SNAPSHOT, certification pending, missing or invalid contract fields, rejected candidate contracts, or non-executable candidate status.
- Are any sleeves clearly weak? Not from the reviewed evidence. The evidence supports 5 flowing sleeves, 4 healthy no-candidate sleeves, and 1 needs-data/runtime-blocked path. It does not support labeling non-producing sleeves as weak without first clearing no-signal, threshold, data, governance, certification, and outcome-maturity conditions.
- What diagnostic fields should be checked before labeling a sleeve weak? Check current_status or throughput_status, evidence_classification, blocker_code, dormant_reason_code, producer_invoked, producer_registered, signal_producer_status, raw_signal_count, candidate_count, market_data_status, trigger_evaluation_status, trigger_thresholds_met, observed_market_conditions, rejection_stage, rejection_reason, rejection_classification, expected_rejection, safety_related, portfolio_gate_reason_codes, contract_validation_status, top_missing_candidate_fields, entry reference price certification, portfolio scoring certification state, evidence_status, sample_status, closed_position_count, and missing_required_inputs.
- Does existing evidence support a reusable interpretation rule? Yes, but the rule is already covered by KNW_0014 and KNW_0015: do not treat low or absent candidate production as sleeve weakness until throughput, no-signal/threshold, data, governance, certification, contract, portfolio-scoring, and outcome-maturity diagnostics have been separated.

Classification result: SUPPORTED.

Rationale: OBS_0014 is supported as a follow-through interpretation discipline. The existing evidence distinguishes healthy selectivity, threshold-not-met behavior, governance suppression, certification bottlenecks, data/runtime blockers, and underpowered outcome evidence. The reviewed artifacts do not support a broad weak-sleeve label for most non-producing sleeves.

New learning objects:
- None. KNW_0014 already captures that low sleeve candidate production can reflect normal no-signal conditions and candidate-generation bottlenecks, and KNW_0015 already captures the raw-signal split between expected portfolio suppression and certification bottlenecks.

No failure entry was created because FAIL_0014 and FAIL_0007 already cover the disproven expectations that low production or candidate volume can be treated as direct quality evidence.

Diagnostic rule: Before labeling a sleeve weak, first classify the evidence path as FLOWING, HEALTHY_NO_CANDIDATE, NEEDS_DATA, NEEDS_GOVERNANCE, NEEDS_REPAIR, or BLOCKED; then separate no-signal or threshold-not-met rows from expected portfolio suppression, certification defects, contract defects, missing data, and outcome-maturity gaps. Only after those fields fail to explain low production should sleeve weakness be considered.

Recommended next action: Evidence-check OBS_0015, focused on whether macro calendar readiness remains research-only and data-bound without event fabrication or paper sleeve creation.

## OBS_0015 Evidence Review

Question: should macro calendar readiness be interpreted as legitimate future research opportunity, unresolved data dependency, blocked implementation path, premature search space, or mixed class?

Evidence found:
- Verified runtime graph for 2026-06-03: graph_status READY.
- Macro calendar data readiness for 2026-06-03: status NEEDS_SOURCE, macro_calendar_ready false, source_status MISSING, event_count 0, valid_event_count 0, invalid_event_count 0, and david_action_required true.
- Macro calendar data readiness identified the missing artifact as aegis_macro_calendar_source_v1/2026-06-03/macro_calendar_source.v1.json and required fields including event_name, event_type, release_datetime, actual, consensus, prior, importance, affected_assets, source, source_timestamp, timezone, and data_quality_status.
- The same artifact preserved safety gates: research_only true, paper_research_only true, no_macro_event_fabrication true, no_shadow_validation_pass_forced true, automatic_paper_sleeve_creation_allowed false, trade_advice_allowed false, broker_execution_allowed false, live_trading_allowed false, and real_capital_allowed false.
- Macro calendar downstream effects routed the path to operator_action_queue PROVIDE_DATA_SOURCE, shadow_validation blocked_by_macro_calendar_data_readiness, shadow_validation_pass_forced false, and workflow_state NEEDS_DATA.
- Data action routing for 2026-06-03 classified the macro row as OPERATOR_PROVIDED_DATA_REQUIRED with blocker_code MISSING_DATA, owner DAVID, and exact buttons Connect Source, Upload Dataset, Mark Not Available, or Defer. It explicitly remained read-only and did not change candidate generation, producer logic, paper lifecycle, trading, broker behavior, or safety gates.
- Hypothesis workflow state for ehp_macro_calendar_fixture: current_state NEEDS_DATA, missing_dataset macro event calendar, macro_calendar_data_readiness_status NEEDS_SOURCE, macro_calendar_ready false, next_action PROVIDE_DATA_SOURCE, resolver_rule_id needs_data_overrides_ready, expected_sample_frequency monthly_or_event_driven, and expected_validation_timeline more than 12 months unless sample rate improves.
- Hypothesis proposal promotion for ehp_macro_calendar_fixture: triage_decision NEEDS_DATA, shadow_validation_result NEEDS_DATA, state NEEDS_DATA, and reason_codes PROPOSAL_LOADED plus missing_macro_event_calendar.
- Generated hypothesis throughput for ehp_macro_calendar_fixture: throughput_status NEEDS_DATA, candidate_count 0, paper_observation_count 0, included_validation_samples 0, closed_outcomes 0, and next_expected_step Connect Source, Upload Dataset, Mark Not Available, or Defer.
- Approved hypothesis paper setup for 2026-06-03: setup_count 0, paper_tracking_ready_count 0, paper_tracking_blocked_count 0, and candidate_generation_eligible_count 0; no macro paper-tracking setup row existed.
- Sleeve throughput evidence classification scorecard for 2026-06-03: ehp_macro_calendar_fixture was current_status BLOCKED, evidence_classification NEEDS_DATA, blocker_code INSUFFICIENT_MARKET_DATA, blocker_reason macro event calendar is missing, owner DAVID, raw_signal_count 0, candidate_count 0, paper_observation_count 0, outcome_count 0, and validation_sample_count 0.
- Research quality engine for ehp_macro_calendar_fixture: quality_status BLOCKED; active hard gates were NO_DATA_SOURCE and INCLUDED_SAMPLES_BELOW_MINIMUM. Data quality was BLOCKED for NO_DATA_SOURCE, implementation completeness was WATCH for NO_PAPER_PATH, economic rationale was PASS for GENERATED_OR_LEGACY_RATIONALE, outcome performance and validation evidence were NOT_APPLICABLE because there were no included validation samples, and robustness was UNDERPOWERED.
- Hypothesis decision policy for 2026-06-03: the macro row recommendation was NEEDS_DATA with active_hard_gates NO_DATA_SOURCE and INCLUDED_SAMPLES_BELOW_MINIMUM, requires_david_review true, and reason codes including MACRO_CALENDAR_DATA_READINESS_NEEDS_SOURCE, missing_macro_event_calendar, NO_DATA_SOURCE, NO_INCLUDED_VALIDATION_SAMPLES, NO_PAPER_PATH, ROBUSTNESS_UNDERPOWERED, and DATA_QUALITY_BLOCKED.
- Research allocation recommendation for 2026-06-03: the macro row had decision_recommendation NEEDS_DATA, recommended_allocation_action PAUSE, current_allocation_weight 0.0, recommended_weight_delta -0.1, and the same no-data, no-sample, no-paper-path, and data-quality-blocked reason codes. It remained read-only with no capital or trade authority.
- Outcome maturity reviews classified ehp_macro_calendar_fixture as low immediate priority or unlikely near-term contributor because it was NEEDS_DATA / NO_DATA_SOURCE / DATA_QUALITY_BLOCKED and should not be repaired by fabricating macro events or creating paper sleeve behavior.
- Journal Review 002 already records FAIL_0012: macro workflow expansion was not a repair for missing macro readiness, because missing or immature data should not be repaired by fabricating events, expanding authority, or creating autonomous sleeve behavior.

Key question answers:
- What specifically is missing? A governed macro event calendar source for 2026-06-03, with event rows containing event_name, event_type, release_datetime, actual, consensus, prior, importance, affected_assets, source, source_timestamp, timezone, and data_quality_status.
- Is the blocker data, implementation, governance, or evidence? Primarily data. The decisive blockers are NEEDS_SOURCE, MISSING_DATA, NO_DATA_SOURCE, missing_macro_event_calendar, and DATA_QUALITY_BLOCKED. There is also a secondary implementation/evidence state because the path has NO_PAPER_PATH, 0 candidates, 0 paper observations, 0 included validation samples, and underpowered robustness. Governance is not the blocker; governance is the guardrail preventing event fabrication, forced shadow validation, paper sleeve creation, or authority expansion.
- If the data existed tomorrow, would the path become research-ready? It would become more assessable and could move from NEEDS_DATA toward shadow validation or setup checks, but the reviewed evidence does not show it would immediately become research-ready. The path would still need governed data quality, paper or observation flow, candidate or setup eligibility where applicable, validation samples, and outcome maturity.
- Is there evidence this path has learning value? Yes, but only as future research opportunity. The economic rationale grade was PASS for generated or legacy rationale, supported event types were defined, and workflow artifacts preserved a specific data-source action path. Learning value is not outcome-proven: there are 0 candidates, 0 paper observations, 0 closed outcomes, and 0 validation samples, with expected validation timeline more than 12 months unless sample rate improves.
- Should the path remain NEEDS_DATA? Yes. Existing artifacts consistently classify it as NEEDS_SOURCE / NEEDS_DATA, and the correct next action is to provide, upload, mark unavailable, or defer the data source rather than create events, sleeves, positions, candidates, or governance changes.

Classification result: MIXED_CLASS.

Rationale: The macro calendar path is a legitimate future research opportunity with a defined rationale and supported event types, but the current evidence state is dominated by unresolved data dependency. It is also not paper-ready or outcome-ready because it has no paper path, no candidates, no observations, no validation samples, and underpowered evidence. It is not unsupported, but it is premature as a search space for candidate or outcome claims until the governed data source exists and subsequent evidence flow appears.

New learning objects:
- None. FAIL_0012 already captures the disproven repair assumption: macro readiness gaps should not be resolved by expanding workflow behavior, fabricating events, or creating autonomous sleeve behavior. KNW_0011 already captures the broader triage lesson that research attention should focus on evidence gaps before allocation decisions.

No failure entry was created because the prior assumption is already captured by FAIL_0012 and was reinforced rather than newly disproven.

Recommended next action: Evidence-check OBS_0010, focused on whether safety gates remain consistent after the macro and candidate-funnel evidence checks.

## OBS_0010 Evidence Review

Question: are the current AEGIS safety gates appropriately supporting research quality, or are they materially reducing learning velocity?

Evidence found:
- Verified runtime graph for 2026-06-03: graph_status READY, while runtime_readiness_status and active_mode_readiness_status were BLOCKED. This preserved evidence review while preventing unsupported runtime/action claims.
- Runtime truth kernel for 2026-06-03: runtime_truth_classification PARTIAL_CONTEXT, highest_readiness_layer BLOCKED, missing_or_stale_source_count 11, trade_advice_allowed false, manual_trade_capture_allowed false, and autonomous_execution_allowed false.
- ChatGPT control packet for 2026-06-03 blocked trade advice because runtime truth PARTIAL_CONTEXT did not allow that capability.
- Safety state authority for 2026-06-03: status BLOCKED, allow_entries false, allow_exits true, canonical_blocker NAV_INVALID, capital_envelope_status FAIL, submit_safety_status BLOCKED, trade_submit_readiness_status FAIL, hard blockers including CAPITAL_RISK_ENVELOPE_NOT_PASS, GLOBAL_KILL_SWITCH_STATE_MISSING, NAV_INVALID, and TRADE_SUBMIT_READINESS_BLOCKED.
- Candidate-to-paper lifecycle for 2026-06-03 still advanced paper learning: 1 valid candidate contract, 1 review-eligible candidate, 1 awaiting review, 1 constructed paper trade, 1 paper position created, and 0 promotion-eligible rows. Safety stayed paper_only true with trade advice, broker execution, autonomous execution, and manual capture all false.
- Candidate contracts for 2026-06-03 showed 1 governed, valid, certified, review-only candidate contract. Automatic approval, autonomous execution, broker execution, and trade advice were all false.
- Hypothesis proposal promotion for 2026-06-03 had 1 paper-promotion recommendation and 1 approval-queue item, while safety remained paper_research_only with automatic paper sleeve creation, real capital, live trading, broker execution, autonomous real-money action, and trade advice all false.
- Macro calendar readiness for 2026-06-03 stayed NEEDS_SOURCE with event_count 0 and valid_event_count 0. Its safety fields explicitly blocked macro event fabrication, forced shadow validation, automatic paper sleeve creation, trade advice, broker execution, live trading, and real capital.
- Hypothesis decision policy for 2026-06-03 produced differentiated research states: 5 CONTINUE, 3 REDESIGN, 1 NEEDS_DATA, 1 DECREASE_ATTENTION, and 0 READY_FOR_CAPITAL_REVIEW. Every decision was read-only with real_capital_allowed false and trade_advice_allowed false.
- Research allocation recommendation for 2026-06-03 produced 5 HOLD, 4 PAUSE, 1 DECREASE, and 0 CAPITAL_REVIEW. It remained read-only and performed no allocation mutation, repair, broker execution, live trading, real capital, or trade advice.
- Research capital allocation self-check for 2026-06-03 passed with allocation_instructions_allowed false, read_only true, trade_advice_allowed false, broker_execution_allowed false, live_trading_allowed false, and autonomous_execution_allowed false.
- Research quality evidence showed 10 hypotheses, 6 underpowered, 4 blocked, and 0 ready for capital review. The most tempting false-promotion path, HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1, had 12 included validation samples against a 30-sample minimum, negative expectancy, drawdown limit breach, negative excess return, low regime coverage, weak sample independence, and underpowered robustness.
- Candidate-funnel reviews separated 40 expected PORTFOLIO_GATE suppressions from 2 safety-related NON_CERTIFIED_CANDIDATE_SNAPSHOT bottlenecks. This improved interpretation without requiring gate changes.
- Journal Review 002 already records the safety-gate interpretation: paper workflow progress is not live readiness, capital review remains premature, and safety gates preserved learning while preventing premature action.

Key question answers:
- Which conclusions were improved because safety gates existed? The reviews could distinguish graph readiness from runtime readiness, paper progress from live readiness, research attention from capital allocation, expected portfolio suppression from certification defects, and macro data dependency from permission to fabricate events.
- Which research paths were delayed because safety gates existed? Real-world action paths were delayed: trade advice, live trading, broker execution, real capital allocation, automatic approval, automatic paper sleeve creation, forced macro shadow validation, and unsupported capital review. Paper research itself was not stopped: candidate-to-paper lifecycle still created 1 paper position, and policy/allocation artifacts still produced differentiated research decisions.
- Did safety gates prevent fabricated evidence, fabricated events, premature promotion, or unsupported capital review? Yes. Macro readiness explicitly blocked event fabrication and forced shadow-validation pass. Candidate contracts stayed review-only. Promotion was paper-research-only. Research quality, decision policy, allocation recommendation, and capital self-check all showed 0 capital-review rows and no capital/trade authority.
- Is there evidence that safety gates are suppressing legitimate learning? Not materially in the reviewed evidence. They suppress actionability and authority, but the evidence surfaces still generated learning: paper position creation, candidate certification checks, candidate-funnel interpretation, macro NEEDS_DATA routing, redesign/continue/decrease decisions, and research allocation triage.
- If a gate were removed tomorrow, what would be the highest-risk failure mode? The highest-risk failure would be converting underpowered or incomplete research evidence into actionable capital/trade claims: HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 could be falsely promoted despite underpowered, negative, concentrated evidence; macro calendar could fabricate events or force validation without data; review-only candidates could be treated as executable.

Classification result: APPROPRIATELY_RESTRICTIVE.

Rationale: The safety gates are restrictive, but the restrictions are aimed at authority, fabrication, and premature action rather than research observation. Existing evidence shows learning continued through read-only paper workflow, candidate certification, macro data routing, outcome maturity, and research triage. The delayed paths were exactly the paths that lacked supporting evidence: trade advice, broker execution, real capital, fabricated macro events, forced validation, and capital review.

New learning objects:
- None. KNW_0009 already captures the reusable lesson that read-only research governance can preserve learning while preventing premature action. KNW_0005, KNW_0011, FAIL_0005, FAIL_0010, and FAIL_0012 already cover the adjacent lessons.

No failure entry was created because no new prior expectation was disproven beyond existing FAIL entries.

Highest-risk removed-gate scenario: premature actionability. Removing the gates would risk treating underpowered paper evidence, review-only candidates, missing macro data, or capital-review-style research triage as trade advice, executable broker action, fabricated validation, or real capital allocation.

Recommended next action: Evidence-check OBS_0018 or revisit OBS_0019 after the current-day verified graph and daily-integrity warnings clear, because those are the remaining runtime-truth and warning-state interpretation questions.

## Understanding Review

The journal improved understanding in three ways:
- It separated paper workflow progress from live readiness.
- It exposed repeated evidence-maturity gaps across outcomes, sleeves, factory evidence, and runtime readiness.
- It turned broad observations into reusable knowledge and failure records without adding new architecture.

The journal did not test trading improvement and should not be evaluated on trading outcomes.

## Pilot Judgment

The journal appears useful for understanding because it made recurring evidence gaps easier to name, reuse, and compare.

Do not add new journal capabilities before observing whether researchers actually reuse these entries.
